vix.ing · top · new · best · stats

Evolution of Hydrogen Sulfide Therapeutics to Treat Cardiovascular Disease

2018/08/17 by Zhen Li, David J. Polhemus, David J. Lefer · 1 citation
Biochemistry, Genetics and Molecular Biology · Medicine · Immunology and Microbiology · #Sulfur Compounds in Biology #Renin-Angiotensin System Studies #Mast cells and histamine

paper · pdf · doi:10.1161/circresaha.118.311134

openalex publication_date 2018/08/17 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01

Abstract

Hydrogen sulfide (H 2 S)—a potent gaseous signaling molecule—has emerged as a critical regulator of cardiovascular homeostasis. H 2 S is produced enzymatically by 3 constitutively active endogenous enzymes in all mammalian species. Within the past 2 decades, studies administering H 2 S-donating agents and the genetic manipulation of H 2 S-producing enzymes have revealed multiple beneficial effects of H 2 S, including vasodilation, activation of antiapoptotic and antioxidant pathways, and anti-inflammatory effects. More recently, the heightened enthusiasm in this field has shifted to the development of novel H 2 S-donating agents that exert favorable pharmacological profiles. This has led to the discovery of novel H 2 S-mediated signaling pathways. This review will discuss recently developed H 2 S therapeutics, introduce signaling pathways that are influenced by H 2 S-dependent sulfhydration, and explore the dual-protective effect of H 2 S in cardiorenal syndrome.

Citations

Cited by

Related